No Data
Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
Sector Update: Health Care Stocks Weaker Late Afternoon
Sector Update: Health Care
Express News | Eli Lilly in Advanced Talks to Buy US Cancer Biotech for up to $2.5Bn- FT